Coagulopathy and Perioperative Hemorrhage and Hematoma (PSI-9)

Document coagulopathy when clinically valid and appropriate, because it reflects the seriousness of the clinical problem at hand.

“Perioperative hemorrhage and hematoma,” also known as Patient Safety Indicator (PSI) 9, is one of the PSIs developed by Agency for Healthcare Research and Quality (AHRQ). PSIs are intended to provide information on potentially avoidable safety events, representing opportunities for improvement in the delivery of care. We have long been focused on improving documentation for the purpose of maximizing the capture of complications and comorbidities (CCs) and major CCs (MCCs); however, as value-based purchasing continues to grow, the importance of improving documentation becomes more relevant and important. However, most important – and this is the theme we should always promote – is documentation for patient care. If we do that, then everything else (revenue and quality metrics) will fall into place.

For a case to be included in a PSI-9 measure, an index procedure performed in the operating room is required, a secondary ICD-10-CM diagnosis code for perioperative hemorrhage or hematoma must be present, and any listed ICD-10-PCS  procedure code for treatment of hemorrhage or hematoma (bedside or OR) must be applied.

Abuabdou 012521

While the measure is titled as perioperative hemorrhage/hematoma, essentially all diagnosis codes listed in the AHRQ specification document (2020) are for postprocedural hemorrhage or hematoma. A clinically valid postprocedural hemorrhage or hematoma requires explicit documentation by the attending surgeon, establishing cause-and-effect relationship.

Unlike other PSIs, PSI-9 is not impacted by the admission type (elective, urgent, or emergent). It means that this measure is applicable to all comers into the organization. It means that in urgent/emergent admissions, wherein the attending surgeon does not have ample time to prep the patient comprehensively in terms of the coagulation system, the opportunity of documenting coagulopathy (when appropriate and clinically valid) becomes invaluable. The diagnosis of coagulopathy (D689) serves as an exclusion from the PSI-9 measure. 

In addition to coagulopathy, there are 31 additional diagnosis codes of coagulation disorders, such as pancytopenia, disseminated intravascular coagulation (DIC), Von Willebrand disease, hemophilia, and thrombocytopenia, which do serve as exclusions to PSI-9 reporting. Interestingly enough, the majority of coagulopathy codes that provide exclusion will risk-adjust the DRG as a CC or MCC.

Code

Diagnosis

Code

Diagnosis

D6109

Other constitutional aplastic anemia CC

D68311

Acquired hemophilia CC

D611

Drug-Induced aplastic anemia MCC

D68312

Antiphospholipid antibody with hemorrhagic disorder CC

D612

Aplastic anemia due to other external agents MCC

D68318

Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors CC

D613

Idiopathic aplastic anemia MCC

D6832

Hemorrhagic disorder due to extrinsic circulating anticoagulants CC

D61810

Antineoplastic chemotherapy induced pancytopenia MCC

D684

Acquired coagulation factor deficiency CC

D61811

Other drug-induced pancytopenia MCC

D688

Other specified coagulation defects CC

D61818

Other pancytopenia CC

D689

Coagulation defect, unspecified CC

D6182

Myelophthisis CC

D691

Qualitative platelet defects

D6189

Other specified aplastic anemias and other bone marrow failure syndromes MCC

D693

Immune thrombocytopenia purpura

D619

Aplastic anemia, unspecified CC

D6941

Evans syndrome

D65

Disseminated intravascular coagulation (defibrination syndrome) MCC

D6942

Congenital and hereditary thrombocytopenia purpura

D66

Hereditary factor VIII deficiency MCC

D6949

Other primary thrombocytopenia

D67

Hereditary factor IX deficiency MCC

D6951

Posttransfusion purpura

D680

Von Willebrand disease CC

D696

Thrombocytopenia, unspecified

D681

Hereditary factor XI deficiency CC

D698

Other specified hemorrhagic conditions

D682

Hereditary deficiency of other clotting factors CC

D699

Hemorrhagic condition, unspecified

If the patient is maintained on anti-platelets (aspirin or clopidogrel) and/or an anti-coagulant (such as Wafarin, Apixaban, Dabigatran, etc.), then the documentation of coagulopathy should be due to anti-coagulation or anti-platelets use, which if linked to the bleeding, becomes clinically valid. Specifying the underlying etiology of coagulopathy is always recommended to consolidate the clinical validity of the diagnosis.

If coagulopathy is documented on the basis of abnormal ROTEM (rotational thromboelastometry, which is a point-of-care test to assess platelet function and coagulation, primarily used in the context of trauma and liver transplantation), then additional clinical relevance, such as the need for, type, and screen in anticipation of blood products transfusion (FFP) to help achieve hemostasis, will solidify the validity of the diagnosis. Please remember that an abnormal coagulation profile (by itself) is not an exclusion from PSI-9 reporting.

When querying attending surgeons for coagulopathy, things to take into consideration include cause-effect relationship, whether the occurrence was unavoidable, and the clinical significance and resource intensity used in the management of the perioperative hemorrhage or hematoma.

Take-home message: document coagulopathy when clinically valid and appropriate, because it reflects the seriousness of the clinical problem at hand.

Programming Note: Listen to Dr. Ahmed Abuabdou report this story live during Talk Ten Tuesdays today at 10 a.m. Eastern.

Facebook
Twitter
LinkedIn

Related Stories

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Heart Failure Coding Essentials: Ensuring Compliance and Optimal Reimbursement

Heart Failure Coding Essentials: Ensuring Compliance and Optimal Reimbursement

Master the complexities of heart failure coding with this expert-led webcast by Emily Montemayor, CCS, CMBCS, COC, CPC, CPMA. Discover strategies to ensure compliance with ICD-10-CM guidelines, documentation integrity, and capture comorbidities like CKD and hypertension. Learn how to resolve coding challenges, improve documentation practices, and submit clean claims to minimize denials and safeguard your organization’s financial health. With practical insights and real-world examples, this session equips you to prevent revenue leakage, enhance compliance, and secure optimal reimbursement—all while supporting better patient outcomes.

February 26, 2025
Decoding 2025 OPPS Charge Capture and Coding Complexities: Strategies for Success

Decoding 2025 OPPS Charge Capture and Coding Complexities: Strategies for Success

Prepare your organization for the 2025 OPPS updates with expert insights from Tiffani Bouchard, CCS, CRCR, a Revenue Integrity Professional with over 30 years of experience. This webcast will address critical challenges in charge capture and coding, providing clarity on APC policies, C-APC packaging, exclusions, and payer-specific requirements. Attendees will learn actionable strategies to ensure compliance, optimize reimbursement, and mitigate risks of claim denials. Gain the knowledge needed to implement updates effectively, educate your team, and maintain seamless revenue cycle operations in the face of evolving OPPS complexities.

January 29, 2025
Enhancing Outcomes with CDI-Coding-Quality Collaboration in Acute Care Hospitals

Enhancing Outcomes with CDI-Coding-Quality Collaboration in Acute Care Hospitals

Join Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, as she presents effective strategies to strengthen collaboration between CDI, coding, and quality departments in acute care hospitals. Angela will also share guidance on implementing cross-departmental meetings, using shared KPIs, and engaging leadership to foster a culture of collaboration. Attendees will gain actionable tools to optimize documentation accuracy, elevate quality metrics, and drive a unified approach to healthcare goals, ultimately enhancing both patient outcomes and organizational performance.

November 21, 2024

Trending News

Featured Webcasts

Rethinking Observation Metrics: Standardizing Data for Better Outcomes

Hospitals face growing challenges in measuring observation metrics due to inconsistencies in classification, payer policies, and benchmarking practices. Join Tiffany Ferguson, LMSW, CMAC, ACM, and Anuja Mohla, DO, FACP, MBA, ACPA-C, CHCQM-PHYADV as they provide critical insights into refining observation metrics. This webcast will address key issues affecting observation data integrity and offer strategies for improving consistency in reporting. You will learn how to define meaningful metrics, clarify commonly misinterpreted terms, and apply best practices for benchmarking, and gain actionable strategies to enhance observation data reliability, mitigate financial risk, and drive better decision-making.

February 25, 2025
Navigating the 2025 Medicare Physician Fee Schedule: Key Changes and Strategies for Success

Navigating the 2025 Medicare Physician Fee Schedule: Key Changes and Strategies for Success

The 2025 Medicare Physician Fee Schedule brings significant changes to payment rates, coverage, and coding for physician services, impacting practices nationwide. Join Stanley Nachimson, MS., as he provides a comprehensive guide to understanding these updates, offering actionable insights on new Medicare-covered services, revised coding rules, and payment policies effective January 1. Learn how to adapt your practices to maintain compliance, maximize reimbursement, and plan for revenue in 2025. Whether you’re a physician, coder, or financial staff member, this session equips you with the tools to navigate Medicare’s evolving requirements confidently and efficiently.

January 21, 2025
Patient Notifications and Rights: What You Need to Know

Patient Notifications and Rights: What You Need to Know

Dr. Ronald Hirsch provides critical details on the new Medicare Appeal Process for Status Changes for patients whose status changes during their hospital stay. He also delves into other scenarios of hospital patients receiving custodial care or medically unnecessary services where patient notifications may be needed along with the processes necessary to ensure compliance with state and federal guidance.

December 5, 2024
Navigating the No Surprises Act & Price Transparency: Essential Insights for Compliance

Navigating the No Surprises Act & Price Transparency: Essential Insights for Compliance

Healthcare organizations face complex regulatory requirements under the No Surprises Act and Price Transparency rules. These policies mandate extensive fee disclosures across settings, and confusion is widespread—many hospitals remain unaware they must post every contracted rate. Non-compliance could lead to costly penalties, financial loss, and legal risks.  Join David M. Glaser Esq. as he shows you how to navigate these regulations effectively.

November 19, 2024

Trending News

Prepare for the 2025 CMS IPPS Final Rule with ICD10monitor’s IPPSPalooza! Click HERE to learn more

Get 15% OFF on all educational webcasts at ICD10monitor with code JULYFOURTH24 until July 4, 2024—start learning today!

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24